This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bollinger, A. Articles by Franzeck, U.K. Search for Related Content PubMed PubMed Citation Articles by Bollinger, A. Articles by Franzeck, U.K. Social Bookmarking                   What's this?

Microvascular Changes in Venous Disease: An Update

Department of Medicine University Hospital CH-8091 Zurich, Switzerland

A.J. Leu, MD

Department of Medicine University Hospital CH-8091 Zurich, Switzerland

U. Hoffmann, MD

Department of Medicine University Hospital CH-8091 Zurich, Switzerland

U.K. Franzeck, MD

Department of Medicine University Hospital CH-8091 Zurich, Switzerland

In an overview the microvascular involvement in chronic venous insufficiency (CVI) is described. Microangiopathy in the lower leg areas is characterized by the presence of typical enlarged and ramified blood capillaries, reduced capillary number, microvascular thrombosis and obliterations, and/or increased permeability of microlymphatics. Transcutaneous oxygen tension (tcPO₂) is decreased and directly correlated to the number of perfused capillaries, whereas laser Doppler flux is enhanced. This apparent paradox may be explained by hyperperfusion in the deeper skin layers (mainly shunt vessels) and hypoperfusion in the superficial nutritive vessels.

Microvascular changes are of patchy distribution. Trophic changes up to overt venous ulceration are mainly caused by microvascular ischemia and edema formation due to increased capillary permeability and deficient lymphatic drainage.

Angiology, Vol. 48, No. 1, 27-32 (1997)
DOI: 10.1177/000331979704800105


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M.R. Cesarone, M.T. De Sanctis, L. Incandela, G. Belcaro, and M. Griffin Microvascular Changes in Venous Hypertension due to Varicose Veins After Standardized Application of Essaven Gel: A Placebo-Controlled, Randomized Study Angiology, December 1, 2001; 52(3_suppl): S11 - S16. [Abstract] [PDF]

				L. Incandela, G. Belcaro, M.R. Cesarone, M.T. De Sanctis, and M. Griffin Microangiopathy and Venous Ulceration: Topical Treatment with Essaven Gel: A Placebo-Controlled, Randomized Study Angiology, December 1, 2001; 52(3_suppl): S17 - S21. [Abstract] [PDF]

				L. Incandela, G. Belcaro, M.R. Cesarone, M.T. De Sanctis, and M. Griffin Changes in Microcirculation in Venous Ulcers with Essaven Gel: A Pilot, Cross-over, Placebo-Controlled, Randomized Study Angiology, December 1, 2001; 52(3_suppl): S23 - S27. [Abstract] [PDF]

				M.T. De Sanctis, L. Incandela, G. Belcaro, and M.R. Cesarone Topical Treatment of Venous Microangiopathy in Patients with Venous Ulceration with Essaven Gel: A Placebo-Controlled, Randomized Study Angiology, December 1, 2001; 52(3_suppl): S29 - S34. [Abstract] [PDF]

				L. Incandela, G. Belcaro, M.R. Cesarone, M.T. De Sanctis, and M. Griffin Microvascular Alterations in Diabetic Microangiopathy: Topical Treatment with Essaven Gel: A Placebo-Controlled, Randomized Study Angiology, December 1, 2001; 52(3_suppl): S35 - S41. [Abstract] [PDF]

				M.R. Cesarone, L. Incandela, G. Belcaro, M.T. De Sanctis, A. Ricci, and M. Griffin Two-Week Topical Treatment with Essaven Gel in Patients with Diabetic Microangiopathy: A Placebo-Controlled, Randomized Study Angiology, December 1, 2001; 52(3_suppl): S43 - S48. [Abstract] [PDF]